ASUS Announces RTX Spark-Powered ProArt Models, Partners With Qualcomm To Deploy Pharmaceutical AI Agent In Taiwan

Pokde.Net reports on two ASUS announcements tied to local AI. The company is showcasing the ProArt P16 and P14 laptops and ProArt GR1X mini PC powered by NVIDIA RTX Spark. The reported top configuration combines a 20-core NVIDIA Grace CPU, a 6,144-core Blackwell GPU, up to 128GB of unified memory, and up to one petaflop of theoretical NVFP4 performance. ASUS also describes thin OLED creator laptops and a compact desktop designed for local AI, creation, and agentic workflows, but these are announced specifications rather than independent performance results.

Separately, Qualcomm and ASUS are launching a Pharmaceutical AI Agent program for more than 50 demonstration pharmacies across Chiayi, Tainan, Kaohsiung, and Pingtung in southern Taiwan. The assistant is designed for frontline pharmacists, helping review medication information and flag potential drug-drug interactions, duplicate therapies, and inappropriate medication use while supporting patient counselling. The system is intended to run locally on edge devices: a 120-billion-parameter cloud model was optimized into a 20-billion-parameter model for on-device inference, using Taiwan Food and Drug Administration package-insert data. The program includes ASUS Zenbook A16 systems with Qualcomm Snapdragon X2 Elite Extreme and Aetina MegaEdge edge-AI hardware.

For Canadian readers, the story is primarily a technology and deployment signal rather than a Canadian product or healthcare announcement. ASUS has not confirmed Canadian pricing, retailer stock, warranty coverage, or launch timing for the RTX Spark ProArt systems, while the pharmacy program is specific to Taiwan's healthcare and regulatory context. Buyers should wait for independent testing of RTX Spark performance, thermals, software compatibility, and privacy controls, and should not treat a pharmacy AI demonstration as evidence that a similar tool is approved or suitable for Canadian medication decisions.